Sparrow Pharmaceuticals Inc

09/08/2026 | Press release | Archived content

Sparrow Pharmaceuticals Appoints George Eldridge as Chief Financial Officer

Sparrow Pharmaceuticals Inc published this content on September 08, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 18, 2026 at 05:44 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]